hard · LSAT Logical Reasoning

In a clinical trial, patients who took a new cholesterol drug had 25 percent fewer heart attacks over five years than patients who received no treatment. The drug's manufacturer concluded that the drug directly prevents heart attacks and should be prescribed broadly to at-risk patients.

Which one of the following, if true, most weakens the manufacturer's conclusion?

  1. The drug is somewhat more expensive to manufacture than several older cholesterol medications already approved for widespread use.
  2. Heart attack rates in the general population have declined gradually over the past several decades due to numerous public health factors.
  3. Patients taking the drug reported that their monthly checkups felt more thorough than any previous medical visits they recalled.
  4. The new cholesterol drug is completely unable to lower any patient's cholesterol level by any measurable amount whatsoever.
  5. Patients given the drug also had to attend monthly checkups that included diet and exercise counseling, unlike the untreated group.

Sign up free to see the explanation and track your rank →

More LSAT Logical Reasoning practice

KomFi: Test Prep Made Easy

KomFi: Test Prep Made Easy — free adaptive practice for GMAT, GRE, SAT, ACT, National Real Estate Exam, Investment Banking, and finance with full explanations.

KomFi Academy is free GMAT prep and personalized GMAT help built as a training platform: 84,500+ practice questions, 28,500+ flashcards, on-demand video lectures, podcasts, and 4K slide decks. Flagship tracks: Free GMAT Prep, Free GMAT Resources, National Real Estate Exam Prep, Investment Banking Prep, Finance Prep, GRE, SAT, ACT, LSAT, MCAT, Financial Accounting, Private Equity, Private Credit, and Quantitative Finance.

Free GMAT Prep & Personalized GMAT Help

What's inside

Topics

View pricing · Read testimonials